Aptly formulated, we conclude, citrus flavonoids hold potential to develop a multitarget treatment of CF combining in a single treatment antimicrobial, anti‐inflammatory, CFTR‐stimulating, and immunomodulatory properties, as required by a genetic disease eventually causing chronic lung inflammation and bacterial infection reinforcing each other. The gene discussed is CFTR; the disease is hereditary disease.